Beebe Healthcare to Hold Two Pediatric (5-11) Vaccination Events Nov. 13 and 20
Update: If you did not come to Beebe's pediatric events in November, there are many options for parents. The Delaware Division of Public Health has multiple standing vaccine sites throughout Delaware. Your local pharmacist or your child's pediatrician may also have the pediatric vaccine, although supplies may be limited. Search here: https://www.vaccines.gov/search/.
Beebe Healthcare will host two pediatric vaccination events on Nov. 13 in Millsboro and Nov. 20 in Lewes. The age range for these events is 5-11. Beebe will be using the Pfizer vaccine that received emergency use authorization for children ages 5-11, which is 1/3 of the adult dose.
Subsequent second-dose events will be held 21 days after at the same location.
Scheduling your child's appointment is easy to do online.
Parents click here to schedule the appointment.
The Nov. 13 event will run 9 a.m. to 1 p.m. at 232 Mitchell Street, Suite 101, Millsboro, DE, 19966. This office is located off of Route 113. Look for the sign with the blue star for where to enter.
The Nov. 20 event will also run 9 a.m. to 1 p.m. but at 33663 Bayview Medical Drive, Unit 3, Lewes, DE, 19958. This office is located off of Savannah Road. Look for the sign with the blue star for where to enter.
If you need help scheduling, rescheduling or canceling your child's COVID vaccine please call 302-648-3215.
While Beebe also offers online scheduling for adult doses of Pfizer (ages 12 and up), pediatric doses will only be offered at these events at this time.
What if this day does not work for me?
There are many options for parents who cannot make these dates. The Delaware Division of Public Health has multiple standing vaccine sites throughout Delaware. Your local pharmacist or your child's pediatrician may also have the pediatric vaccine, although supplies may be limited.
When was the pediatric dose approved, and how do we know it is safe?
On November 2, 2021, the Centers For Disease Control and Prevention and the Advisory Committee on Immunization Practices authorized the use of Pfizer-BioNTech vaccine for ages 5 to 11. The CDC’s recommendations followed the U.S. Food & Drug Administration’s approval to expand the Emergency Use Authorization (EUA) to allow for the Pfizer vaccine to be administered to children in this age group.
Several studies were conducted on 5,000 children ages 5-11. The vaccine was determined to be safe, no severe vaccine-related side effects were reported. Additionally, no reports of myocarditis or anaphylaxis.
The vaccine was found to be 90 percent effective against developing symptomatic COVID-19.
If you have questions whether the Pfizer COVID-19 vaccine is right for your child please contact your primary care provider.
What about side effects?
Side effects reported were similar or fewer thank those experienced by adults.
Side effects could include sore arms, fatigue, headaches, muscle pain, chills, and low grade fevers lasting a day or two.
Reducing potential side effects was one reason the dosage was lowered for those 5-11.